TIAM1 and hepatocellular carcinoma: Multiple HCC cell lines were assessed to identify lines that could be used as models for HCC subgroup-2 (to allow testing of the functional relevance of TIAM1), as well as controls that could be used as models for non-HCC-subgroup-2 (i.e., derived from HCC not associated with subgroup-2).